Top Markets
Coin of the day
MicroPort NeuroTech Limited MicroPort NeuroTech Limited

MicroPort NeuroTech Limited

2172
Rank in Stocks #11874
Established in 2004 and headquartered in Shanghai, People's Republic of China,... Established in 2004 and headquartered in Shanghai, People's Republic of China, MicroPort NeuroTech Limited is dedicated to the research, development, manufacturing, and global commercialization of neuro-interventional medical devices. The company's diverse product portfolio addresses various cerebrovascular conditions. For treating hemorrhagic stroke, it offers the NUMEN coil embolization system, the NUMEN FR coil detachment system, the Tubridge flow-diverting stent, the Willis intracranial stent graft system, and the Rebridge intracranial visualized stent. Additionally, MicroPort NeuroTech supplies the APOLLO intracranial arterial stent system for intracranial atherosclerotic disease, as well as the Bridge rapamycin target eluting vertebral artery stent system specifically designed for cerebral atherosclerotic stenosis. To address acute ischemic stroke, the company provides the Neurohawk stent thrombectomy device and the Tigertriever adjustable stent retriever.
Share Price
$1.04
Market Cap
$603.62M
Change (1 day)
-2.52%
Change (1 year)
-38.05%
Country
CN
Trade MicroPort NeuroTech Limited (2172)

Category

Stock price history for MicroPort NeuroTech Limited (2172)
Highest end of day price: $1.11 on 2026-08-01

Lowest end of day price: $3.13 on 2022-07-01
Stock price history of MicroPort NeuroTech Limited from 2022 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 3.36%
2025 17.54%
2024 -25.73%
2023 -42.14%
2022 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$112.64 -15.09%
US
$331.44 -15.32%
US
$91.30 -1.63%
IE
$46.83 -55.61%
US
$46.88 -15.20%
DE